ACCESS Newswire

Heston Capital Pty Ltd

4.6.2024 13:59:44 CEST | ACCESS Newswire | Press release

Share
Heston Capital Pty Ltd Poised for Record-Breaking Q2 2024

Heston Capital Pty Ltd has Already Posted a Record-Breaking Q2 2024 Amidst Major Private Equity Transactions

LONDON, UNITED KINGDOM / ACCESSWIRE / June 4, 2024 / Heston Capital Pty Ltd, a leading wealth manager, specializing in investments across diverse sectors, is thrilled to announce its exceptional performance and record-breaking second quarter for 2024. Bolstered by a series of strategic investments in key industries such as aerospace, artificial intelligence (AI), and satellite internet, Heston Capital has delivered unparalleled value to its clients and shareholders.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

Aerospace, AI, and Satellite Internet Providers: Driving Growth and Innovation

Heston Capital's success in Q2 2024 can be attributed to its foresight and expertise in identifying lucrative early opportunities within high-growth sectors. With a keen focus on aerospace advancements, groundbreaking AI technologies, and the burgeoning satellite internet industry, Heston Capital has made strategic investments that not only generate substantial returns but also contribute to shaping the future of these industries.

Exceptional Start to 2024: Delivering Value to Shareholders

The recent groundbreaking private equity transactions undertaken by Heston Capital have yielded remarkable results, surpassing expectations and setting new benchmarks for success. By leveraging its extensive network, market insights, and investment acumen, Heston Capital has consistently solidified its position as a trusted partner in wealth creation.

A Commitment to Innovation and Growth

At Heston Capital, innovation and growth are at the core of our ethos. As we continue to navigate the evolving landscape of private equity, we remain dedicated to identifying and capitalizing on emerging opportunities that drive value creation and foster long-term prosperity for our stakeholders.

"We are immensely proud of our achievements this year," said Michael Silverman, Head of Private Equity at Heston Capital. "Our strategic investments in key sectors such as aerospace, AI, and satellite internet have not only delivered exceptional returns but also positioned us at the forefront of industry innovation. We remain committed to pursuing opportunities that drive value for our clients and shareholders while contributing to the advancement of transformative technologies."

About Heston Capital Pty Ltd

Heston Capital Pty Ltd is a leading wealth manager, heavily focused on private equity, with offices in Australia, London and Dubai. With a focus on industries at the forefront of innovation, Heston Capital is dedicated to shaping the future of global markets through visionary investments and transformative partnerships.

For Media Inquiries, Please Contact:

Mr. Patrick Fay
Public Relations Officer
patrick.fay@hestoncapital.com

SOURCE: Heston Capital Pty Ltd



View the original press release on accesswire.com

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release

Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release

OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release

CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in

CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release

TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye